CDKN2A and cancer: For instance, irreversible cell cycle arrest, decreased BrdU incorporation, upregulation of Cdkn2a, morphological changes, and SA-β-gal activity were detected in mouse embryonic fibroblasts [26]; morphologic alterations, gamma-H2AX and 53BP1 foci, and the SASP were analyzed in chemotherapy-treated cancer cell lines.